Skip to main content
TDAC logo

Translational Development Acquisition Corp. (TDAC) Stock Price & Analysis

Translational Development Acquisition Corp. (TDAC) — MoonshotScore 42/100 (Weak band), calculated Nov 18, 2026. Price $10.90 (+0.18%), as of the Nov 19, 2026 trading session; market cap $210M.

Educational signal · not a buy or sell recommendation · How to read this

$10.90 +$0.0195 (+0.18%) Market Cap $210M

Translational Development Acquisition Corp. · TDAC · NASDAQ

Translational Development Acquisition Corp. is a shell company focused on identifying and merging with a private business.

Price as of Nov 19, 2026

Key Statistics

42 of 100

MoonshotScore v2 · Translational Development Acquisition (TDAC)

Weak
Business Quality Poor (14)
Financial Safety Okay (40)
Valuation Bubble (13)
Growth Durability Shrinking (2)
Momentum Rising (65)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, stalling growth and an expensive valuation, though the balance sheet is only middling. Business Quality: Poor; Financial Safety: Okay; Valuation: Bubble; Growth Durability: Shrinking; Momentum: Rising.

  • Altman Z 8.18 · Piotroski F 2
  • ROE 3.3% · ROA 3.5% · current ratio 0.06 · earnings yield 3.0% · free-cash-flow yield -0.3%

Holding back: weak fundamentals, a rich price, soft growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for TDAC (57 recorded, newest six shown)
RecordedScoreBand
48Fair
46Fair
48Fair
48Fair
42Weak
42Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$10.90
Change on the day+0.18%
52-week range$10.41 – $10.95
Market capitalisation$210M—
Price / earnings (trailing)42.24
Shares traded on the day83.0K

Price & events

Other perspectives

Council score for Translational Development Acquisition (TDAC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Neutral
Valuation Negative
Growth Durability Negative
Momentum Moderate

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Overvalued
Profit Margin Weak
ROE Weak
Gross Margin Negative

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Translational Development Acquisition (TDAC), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Translational Development Acquisition Corp. (TDAC) is listed on NASDAQ. It employs 2 people and is led by Michael Hoffman. The market values it at $210M.

3 · Financial strengths and risks

What are the financial strengths and risks for Translational Development Acquisition (TDAC)?

Short answer · as of

What is holding it back is weak fundamentals, a rich price, soft growth. The distress and quality screens read Altman Z 8.18 · Piotroski F 2. Trailing ratios: ROE 3.3% · ROA 3.5% · current ratio 0.06 · earnings yield 3.0% · free-cash-flow yield -0.3%.

5 · Peer comparison

How does Translational Development Acquisition compare with its peers?

Short answer

Translational Development Acquisition's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Cantor Equity Partners I, Inc. (CEPO) Same industry, near in market value$10.84 Nov 19, 2026$276M59 5-pillar Nov 18, 2026
FG Imperii Acquisition Corp. Class A Ordinary Shares (FGII) Same industry, near in market value$10.10 Nov 19, 2026$292M57 5-pillar Nov 18, 2026
LaFayette Acquisition Corp. (LAFA) Same industry, near in market value$10.23 Nov 19, 2026$161M54 5-pillar Nov 18, 2026
NMP Acquisition Corp. (NMP) Same industry, near in market value$10.45 Nov 19, 2026$167M52 5-pillar Nov 18, 2026
Indigo Acquisition Corp. (INAC) Same industry, near in market value$10.45 Nov 19, 2026$154M52 5-pillar Nov 18, 2026
Pono Capital Corp. (PONO) Same industry, near in market value$10.08 Nov 19, 2026$227M50 5-pillar Nov 18, 2026
CRAC (CRAC) Same industry, near in market value$10.30 Nov 19, 2026$231M49 5-pillar Nov 18, 2026
Copley Acquisition Corp (COPL) Same industry, near in market value$10.74 Nov 19, 2026$255M49 5-pillar Nov 18, 2026
Drugs Made In America Acquisition Corp. (DMAA) Same industry, near in market value$10.90 Nov 19, 2026$265M48 5-pillar Nov 18, 2026
RF Acquisition Corp II (RFAI) Same industry, near in market value$33.50 Nov 19, 2026$252M47 5-pillar Nov 18, 2026
Bold Eagle Acquisition Corp. (BEAG) Same industry, near in market value$10.62 Nov 19, 2026$169M47 5-pillar Nov 18, 2026
Lionheart Holdings (CUB) Same industry, near in market value$10.97 Nov 19, 2026$287M47 5-pillar Nov 18, 2026
Translational Development Acquisition (TDAC) — this page$10.90$210M42

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
1
Identified insiders
1
Purchases
1
Sales
0
Other transactions
0

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held TDAC in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported TDAC in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Translational Development Acquisition (TDAC)?

Read these with our analysis →

Common Questions About TDAC

These answers are editorial: 1 of these 9 answers is drawn from the TDAC research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for TDAC?

TDAC carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is TDAC a good stock to buy?

Stock Expert AI does not rate TDAC buy, sell or hold. Translational Development Acquisition Corp. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the TDAC stock price today?

The last price recorded for Translational Development Acquisition Corp. (TDAC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does Translational Development Acquisition Corp. do?

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC). It does not have any operating business. It was formed to raise capital through an initial public offering (IPO) with the sole purpose of acquiring or merging with an existing private company. The goal is to take the private company public without the traditional IPO process.

What are the key factors to evaluate for TDAC?

Translational Development Acquisition Corp. (TDAC) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Market size: Varies by sector. Not financial advice.

How frequently does TDAC data refresh on this page?

TDAC's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven TDAC's recent stock price performance?

Translational Development Acquisition Corp. (TDAC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team (if applicable). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TDAC overvalued or undervalued right now?

The trailing P/E of Translational Development Acquisition Corp. (TDAC) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of TDAC?

Fractional-share availability for Translational Development Acquisition Corp. (TDAC) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 6 from Financial Modeling Prep (FMP), 6 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.